Tier 2 MSK Service for NHS MSE ICB

Concepts

• health services
• basildon
• msk services
• own msk services
• service delivery quality
• nhs mse icb
• nhs mid
• nhs mid and south essex integrated care board
• icb
• tier 2 msk services

Location

Basildon

Description

This is a voluntary ex ante transparency notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 MSK Services to the patients within Mid and South Essex's geographical footprint. The contract will be for 7 months, with the option to extend for a further 5 months, from 01st April 2023 - 31st March 2024 . The aggregate contract value is forecasted at £1,063,075.

Total Quantity or Scope

The Service to which this procurement relates fall within Schedule 3 of the Public Contracts Regulations 2015 as amended by as amended by The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020, (the "Regulations"). As such, the Authority does not intend to hold itself bound by any of the Regulations, save those applicable to Schedule 3 Services. This is a voluntary ex ante transparency notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 MSK Services to the patients within Mid and South Essex's geographical footprint. The contract will be for 7 months, with the option to extend for a further 5 months, from 01st April 2023 - 31st March 2024 . The aggregate contract value is forecasted at £1,063,075. The Authority has taken the decision to award this Tier 2 MSK Service (which was previously for Thurrock CCG) to incumbent provider Thurrock Health Hubs. The provider is considered most technically capable of providing the most economically advantageous solution to the Authority under the current environment whilst the ICB undergoes restructure, review and alignment of contracts. The Authority is applying the NHS Standard Contract Terms and Conditions to support a combination of services, all of which are part funded under a single clinical contract, to ensure appropriate clinical governance and service delivery quality as well as consistency of service to patients. This notice is being published to reflect the date by which the Authority has satisfied it's internal governance process and the Authority's signatures have been ascertained, not at the time of the proposed start-date of this contract. The Authority will observe a 10-day standstill from the date of publication of this notice. The Authority is commencing a procurement-process for it's own MSK Services for the whole of the ICB and will publish appropriate Notices accordingly to communicate any such future changes and opportunities to the market, once final.

Award Detail

Renewal Options

Option to extend for a further 5 months (01/04/23 - 31/03/24)

CPV Codes

• 85100000 - Health services

Indicators

• Options are available.
• Award on basis of price and quality.

Legal Justification

The Authority has taken a decision to award a contract to the incumbent provider as it is considered to be the most technically capable provider in the current environment, whilst the ICB undergoes its own procurement process to formally award this service. This award is made to ensure quality, safety and consistency in provision of care that meet the needs of the population during this transition period. The Authority will publish appropriate Notices accordingly to communicate any such future changes and opportunities to the market, once final.

Other Information

The Service to which this procurement relates fall within Schedule 3 of the Public Contracts Regulations 2015 as amended by as amended by The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020, (the "Regulations"). As such, the Contracting Authority does not intend to hold itself bound by any of the Regulations, save those applicable to Schedule 3 Services.